Zobrazeno 1 - 10
of 65
pro vyhledávání: '"A. Vennepureddy"'
Publikováno v:
Case Reports in Oncological Medicine, Vol 2016 (2016)
The cooccurrence of more than one oncologic illness in a patient can present a diagnostic challenge. Here we report an unusual case of concomitant existence of multiple myeloma, breast cancer, and monoclonal B-cell lymphocytosis on initial presentati
Externí odkaz:
https://doaj.org/article/dc81c1d1272b4e13bb142855604e7061
Publikováno v:
Case Reports in Medicine, Vol 2021 (2021)
Vulvar cancer accounts for about 5% of cancer of female genitalia. It may initially present as benign symptoms resulting in potential delay in diagnosis. Few cases of distant metastases to skin or breast have been reported. We present the case of a 7
Externí odkaz:
https://doaj.org/article/9105f86adf194fdda5003a89665a7c1d
Autor:
Adhikari, Nawaraj1 (AUTHOR), Vennepureddy, Adarsh2 (AUTHOR), Parylo, Sara2 (AUTHOR), Agarwal, Anupma3 (AUTHOR), Dhar, Meekoo2 (AUTHOR)
Publikováno v:
Case Reports in Medicine. 1/19/2021, p1-3. 3p.
Publikováno v:
Case Reports in Medicine, Vol 2021 (2021)
Case Reports in Medicine
Case Reports in Medicine
Vulvar cancer accounts for about 5% of cancer of female genitalia. It may initially present as benign symptoms resulting in potential delay in diagnosis. Few cases of distant metastases to skin or breast have been reported. We present the case of a 7
Publikováno v:
World Journal of Oncology
Treatment of lung cancer has been revolutionized with development of drugs that target key driver mutations and immune checkpoints. Until recently, it was believed that these driver mutations are mutually exclusive. However, few reports have emerged
Publikováno v:
Case Reports in Oncological Medicine. 5/10/2016, p1-4. 4p.
Publikováno v:
OncoTargets and Therapy, Vol 2016, Iss Issue 1, Pp 4843-4858 (2016)
Nishitha Thumallapally,1 Hana Yu,1 Divya Asti,1 Adarsh Vennepureddy,1 Terenig Terjanian2 1Department of Internal Medicine, 2Division of Hematology and Oncology, Staten Island University Hospital, New York, NY, USA Abstract: The treatment landscape fo
Publikováno v:
OncoTargets and therapy
The treatment landscape for multiple myeloma (MM) is evolving with our understanding of its pathophysiology. However, given the inevitable cohort heterogeneity in salvage therapy, response to treatment and overall prognoses tend to vary widely, makin
Autor:
Terenig Terjanian, Vijeyaluxmy Motilal Nehru, Nishitha Thumallapally, Jean-Paul Atallah, Adarsh Vennepureddy
Publikováno v:
Journal of Clinical Medicine Research
Metastatic melanoma (MM) still remains as one of the most worrisome cancer known to mankind. In last two decades, treatment of melanoma took a dramatic turn with the discovery of targeted therapy which targets the mutations in mitogen-activated prote
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 25(1)
Cyclin-dependent kinase 4/6 inhibitors, which act by inhibiting progression from the G1 to S phases of the cell cycle, include palbociclib, ribociclib, abemaciclib, and trilaciclib. Palbociclib and ribociclib are currently food and drug administratio